The present invention provides for a modified TIE-2 ligand 2 which has been altered by addition, deletion or substitution of one or more amino acids, or by way of tagging, with for example, the Fc portion of human IgG-1, but which retains its ability to bind the TIE-2 receptor.

 
Web www.patentalert.com

< Bifunctional chelating agent for actinium

< Lactoferrin in the treatment of diabetes mellitus

> Method for identifying compounds in vitro that modulate the dysregulation of transcription of transcription mediated by mutant huntingtin protein

> Method for the production of bacterial toxins
~ 00262